| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | Inquire | Inquire | 20 nmol, 50 nmol, 100 nmol, 200 nmol | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT00060WQ is a type of small interfering RNA (siRNA) that targets ADA gene and regulates the expression of gene. The siRNA interferes with the expression of ADA gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potentialThe product SIRGT00060WQ is a type of small interfering RNA (siRNA) that targets ADA gene and regulates the expression of gene. The siRNA interferes with the expression of ADA gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Bifidobacterium is Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They wre originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In Bifidobacterium is Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They wre originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In humans, Bifidobacterium resides within the GI tract, from birth to old age. Disturbances in the microbiota are linked to an ever-growing number of immune-linked disease states including IBD, atopic allergy, arthritis, and obesity. Therefore, there is a significant interest in treating these diseases through microbial or "probiotic" supplementation of patients, including Bifidobacterium. Data from mouse models and clinical trials indicate that Bifidobacterium may have beneficial effects for treating and preventing immune-linked diseases, including gut-associated and systemic conditions. Bifidobacterium have been commercially exploited as probiotic agents due to their associated health benefits and GRAS.... Read More | Rabbit corneal epithelial cells (RbCEpC) are isolated from rabbit corneal epithelial tissue, which covers and protects the cornea from bacteria and other harmful organisms and substances. RbCEpC is cryopreserved in the X generation, and is cultivated and propagated at least when the X population hasRabbit corneal epithelial cells (RbCEpC) are isolated from rabbit corneal epithelial tissue, which covers and protects the cornea from bacteria and other harmful organisms and substances. RbCEpC is cryopreserved in the X generation, and is cultivated and propagated at least when the X population has doubled.... Read More | The product SIRGT90970WQ is a type of small interfering RNA (siRNA) that targets Plcl2 gene and regulates the expression of gene. The siRNA interferes with the expression of Plcl2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has The product SIRGT90970WQ is a type of small interfering RNA (siRNA) that targets Plcl2 gene and regulates the expression of gene. The siRNA interferes with the expression of Plcl2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | The product SIRGT30937WQ is a type of small interfering RNA (siRNA) that targets ERN2 gene and regulates the expression of gene. The siRNA interferes with the expression of ERN2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has The product SIRGT30937WQ is a type of small interfering RNA (siRNA) that targets ERN2 gene and regulates the expression of gene. The siRNA interferes with the expression of ERN2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |